2003
Retinoids and Drugs of Abuse: Implications for Neurological Disease Risk in Human Immunodeficiency Virus Type 1 Infection
Royal W, Vlahov D, Lyles C, Gajewski C. Retinoids and Drugs of Abuse: Implications for Neurological Disease Risk in Human Immunodeficiency Virus Type 1 Infection. Clinical Infectious Diseases 2003, 37: s427-s432. PMID: 14648459, DOI: 10.1086/377554.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virus type 1 (HIV-1) infectionVirus type 1 infectionType 1 infectionDrug usersSeronegative control subjectsRetinoic acidDevelopment of HIVInjection drug usersTumor necrosis factorNervous system diseasesLevels of retinolMononuclear cell lineNeurological disease riskTrans retinoic acidDrugs of abuseRetinoid administrationClinical outcomesRetinol-binding proteinImmunomodulatory effectsControl subjectsNecrosis factorSystem diseasesNeurological diseasesHIVDisease risk
1995
Normative Data for a Brief Neuropsychologic Test Battery in a Cohort of Injecting Drug Users
Concha M, Seines O, McArthur J, Nance-Sproson T, Updike M, Royal W, Solomon L, Vlahov D. Normative Data for a Brief Neuropsychologic Test Battery in a Cohort of Injecting Drug Users. Substance Use & Misuse 1995, 30: 823-841. PMID: 7558472, DOI: 10.3109/10826089509067009.Peer-Reviewed Original Research